Antibiotic use and resistance in the intensive care unit

Current Opinion in Critical Care

Volumn 3, Issue 5, 1997, Pages 348-354

  Rice, Louis B ^a   Toltzis, Philip ^a  

^a LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0005518921     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Pinner RW, S.M. T, Simonsen L, Klug LA, Graber JM, Clarke MJ, Berkelman RL: Trends in infectious diseases mortality in the United States. JAMA 1996, 275:189-193.
2. Burwen DR, Banerjee SN, Gaynes RB, System and the NNIS (National Nosocomial Infection Surveillance): Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J Infect Dis 1994, 170:1622-1625.
3. Centers for Disease Control and Prevention: Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. MMWR Morbid Mortal Wkly Rep 1993, 42:597-599.
4. Pena C, Albareda JM, Pallares R, Pujol M, Tubau F, Ariza J: Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections. Antimicrob Agents Chemother 1995, 39:520-524.
5. Steinberg JP, Clark CC, Hackman BO: Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of Intravascular devices and methicillin resistance. Clin Infect Dis 1996, 23:255-259.
6. Dowson CG, Johnson AP, Cercenado E, George RC: Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother 1994, 38:49-53.
7. Bush K, Jacoby GA, Medeiros AA: A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995, 39:1211-1233.
8. Schrag SJ, Perrot V: Reducing antibiotic resistance. Nature 1996, 381:120-121.
9. Williams DR, Thomas CM: Active partitioning of bacterial plasmids. J Gen Microbiol 1992, 138:1-16.
10. Spencer RC: The emergence of epidemic multi-antibiotic-resistant Stenotropomonas maltophilia and Burkholderia cepacia. J Hosp Infect 1995, 30(suppl):453-464.
11. Peacock JE, Marsik FJ, Wenzel RP: Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med 1980, 93:526-532.
12. Preheim LC, Rimland D, Bittner MJ: Methicillin-resistant Staphylococcus aureus in Veterans Administration Medical Centers. Infect Control 1987, 8:191-194.
13. Moreno F, Crisp C, Jorgensen JH, Patterson JE: Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995, 21:1308-1312.
14. Rhinehart E, Shlaes DM, Serkey J, Keys T, Serkey J, Kirkley B, Kim C, Currie-McCumber CA, Hall G: Clonal dissemination of methicillin-resistant Staphylococcus aureus (MRSA) identified by plasmid analysis. Arch Intern Med 1987, 147:521-524.
15. Rosdahl VT, Knudsen AM: The decline of methicillin resistance among Danish Staphylococcus aureus strains. Infect Control Hosp Epidemiol 1991, 12:83-88.
16. Sherertz RJ, Reagan DR, Hampton KD, Robertson KL, Streed SA, Hoen HM, Thomas R, Gwaltney JM Jr: A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 1996, 124:539-547.
17. Sanford MD, Widmer AD, Bale MJ, Jones RN, R. P. W: Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994, 19:1123-1128.
18. Murray BE: The life and times of the enterococcus. Clin Microbiol Rev 1990, 3:46-65.
19. Noble WC, Virani Z, Gee RGA: Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992, 93:195-198.
20. Rice LB, Carias LL, Marshall SH, Bonafede MC: Sequences found on staphylococcal β-lactamase plasmids integrated into the chromosome of Enterococcus faecalis CH116. Plasmid 1996, 35:81-90.
21. Linden PK, Pasculle AW, Manez R, Kramer DJ, Fung JJ, Pinna AD, Kusne S: Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996, 22:663-670.
22. Montecalvo MA, Horowitz H, Gedris C, Carbonaro C, Tenover FC, Issah A, Cook P, Wormser GP: Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994, 38:1363-1367.
23. Williamson R, LaBouguenec C, Gutmann L, Horaud T: One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to penicillin. J Gen Microbiol 1985, 131:1933-1940.
24. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB: Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978, 298:531-534.
25. Arthur M, Molinas C, Depardieu F, Courvalin P: Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol 1993, 175:117-127.
26. Evers S, Courvalin R: Regulation of VanB-type vancomycin resistance gene expression by the vanSB-VanRB two component regulatory system in Enterococcus faecalis V583. J Bacteriol 1996, 178:1302-1309.
27. Rice LB: The theoretical origin of vancomycin-resistant enterococci. Clin Microbiol Newslett 1995, 17:189-192.
28. Morris JG, Shay DK, Hebden JN, McCarter RJ Jr, Perdue BE, Jarvis W, Johnson JA, Dowling TC, Polish LB, Schwalbe RS: Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995, 123:250-259.
29. Wells CL, Juni BA, Cameron SB, Mason KR, Dunn DL, Ferrieri P, Rhame FS: Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995, 21:45-50.
30. Centers for Disease Control and Prevention: Preventing the spread of vancomycin resistance: report from the Hospital Infection Control Practices Advisory Committee. Federal Register 1994, 59:25758-25763.
31. Boyce JM, Opal SM, Chow JW, Zervos MJ, Potter-Bynoe G, Sherman CB, Romulo RL, Fortna S, Medeiros AA: Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994, 32:1148-1153.
32. Boyce JM, Mermel LA, Zervos MJ, Rice LB, Potter-Bynoe G, Giogio C, Medeiros AA: Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995, 16:634-637.
33. Slaughter S, Hayden MK, Nathan C, Hu T-C, Rice T, Van Voorhis J, Matushek M, Franklin C, Weinstein RA: A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996, 125:448-456. This study is in contrast to the two studies by Boyce et al. (J Clin Microbiol 1994, 32:1148-1153 and Infect Control Hosp Epidemiol 1995, 16:634-637) that demonstrated control of two outbreaks of monoclonal vancomycin-resistant enterococci by use of strict gown and glove precautions for infected and colonized patients. It emphasizes the difficulty of eradicating polyclonal outbreaks with infection control techniques.
34. Slaughter S, Hayden MK, Nathan C, Hu T-C, Rice T, Van Voorhis J, Matushek M, Franklin C, Weinstein RA: A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996, 125:448-456. This study is in contrast to the two studies by Boyce et al. (J Clin Microbiol 1994, 32:1148-1153 and Infect Control Hosp Epidemiol 1995, 16:634-637) that demonstrated control of two outbreaks of monoclonal vancomycin-resistant enterococci by use of strict gown and glove precautions for infected and colonized patients. It emphasizes the difficulty of eradicating polyclonal outbreaks with infection control techniques.
35. Slaughter S, Hayden MK, Nathan C, Hu T-C, Rice T, Van Voorhis J, Matushek M, Franklin C, Weinstein RA: A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996, 125:448-456. This study is in contrast to the two studies by Boyce et al. (J Clin Microbiol 1994, 32:1148-1153 and Infect Control Hosp Epidemiol 1995, 16:634-637) that demonstrated control of two outbreaks of monoclonal vancomycin-resistant enterococci by use of strict gown and glove precautions for infected and colonized patients. It emphasizes the difficulty of eradicating polyclonal outbreaks with infection control techniques.
36. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, Wenzel RP: Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995, 20:1126-1133.
37. Moreno F, Grota P, Crisp C, Magnon K, Melcher GP, Jorgensen JH, Patterson JE: Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995, 21:1234-1237.
38. Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K: Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996, 23:1020-1025.
39. Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F: Cephalosporins as a risk factor for nosocomial Enterococcus faecalis bacteremia. Arch Intern Med 1993, 153:1581-1586.
40. Fontana R, Grossato A, Rossi L, Cheng YR, Satta G: Transition from resistance to hypersusceptibility to β-lactam antibiotics associated with loss of a low affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillin. Antimicrob Agents Chemother 1985, 28:678-683.
41. Chirurgi VA, Oster SE, Goldberg AA, McCabe RE: Nosocomial acquisition of β-lactamase-negative, ampicillin-resistant enterococcus. Arch Intern Med 1992, 152:1457-1461.
42. Sirot DL, Goldstein RW, Soussy CJ, Courtieu AL, Husson MO, Lemozy J, Meyran M, Morel C, Prerez R, Quentin-Noury C, et al.: Resistance to cefotaxime and seven other β-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother 1992, 36:1677-1681.
43. Itokazu GS, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA: Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a post-marketing surveillance program. Clin Infect Dis 1996, 23:779-784.
44. Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R: Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infec Dis 1997, 24:211-215.
45. Jacoby GA, Archer GL: New mechanisms of bacterial resistance to antimicrobial agents. N Engl J Med 1991, 324:601-612.
46. Jacobs C, Joris B, Jamin M, Klarsov K, Van Beeumen J, Mengin-Lecreuix D, van Heijenoort J, Park JT, Normark S, Frère J-M: AmpD, essential for both β-lactamase regulation and cell wall recycling, is a novel cytosolic N-acetylmuramyl-L-alanine amidase. Mol Microbiol 1995, 15:553-559.
47. Medeiros AA: Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin Infect Dis 1997, 24(suppl 1):S19-S45. An excellent, comprehensive review of the evolution of these complex and exceedingly important molecules.
48. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ: Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993, 119:353-358.
49. Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano M, Masinkia-Snipas K, Rahal JJ: Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymixin B and sulbactam. Lancet 1994, 344:1329-1332.
50. Rice LB, Eckstein EC, DeVente J, Shlaes DM: Ceftazidime-resistance Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996, 23:118-124.
51. Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC Jr, Jacoby GA: Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 1990, 34:2193-2199.
52. Franco JA, Eitzman DV, Baer H: Antibiotic usage and microbial resistance in an intensive care nursery. Am J Dis Child 1973, 126:318-321.
53. McKee KT, Cotton RB, Stratton CW, Lavely GB, Wright PF, Shenai JP, Evans ME, Melly MA, Farmer JJ, Karzon DT, et al.: Nursery epidemic due to multiply-resistant Klebsiella pneumonias: epidemiologic setting and impact on perinatal health care delivery. Infect Control 1982, 3:150-156.
54. Reish O, Ashkenazi S, Naor N, Samra Z, Merlob P: An outbreak of multiresistant Klebsiella in a neonatal intensive care unit. J Hosp Infect 1993, 25:287-291.
55. Acolet D, Ahmet Z, Houang E, Hurley R, Kaufmann ME: Enterobacter cloacae in a neonatal intensive care unit: account of an outbreak and its relationship to use of third generation cephalosporins. J Hosp Infect 1994, 28:273-286.
56. Soulier A, Barbut F, Ollivier JM, Petit JC, Lienhart A: Decreased transmission of Enterobacteriaceae with extended-spectrum β-lactamasas in an intensive care unit by nursing reorganization. J Hosp Infect 1995, 31:89-97.
57. Chow JW, Fine MJ, Shlaes DM, Quinn JP: Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991, 115:585-590.
58. Quinn JP, DiVincenzo CA, Foster J: Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections. J Infect Dis 1987, 155:942-947.
59. Johnson MP, Ramphal R: β-Lactam-resistant Enterobacter bacteremia in febrile neutropenic patients receiving monotherapy. J Infect Dis 1990, 162:981-983.
60. Jacobson KL, Cohen SH, Inciardi JF, King JH, Lippert WE, Iglesias T, Van Couwenberghe CJ: The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I β-lactamase-producing organisms. Clin Infect Dis 1995, 21:1107-1113.
61. Lucet J-C, Chevret S, Decre D, Vanjak D, Macrez A, Bedos J-P, Wolff M, Regnier B: Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996, 22:430-436.
62. Carmeli Y, Samore MH: Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. Clin Infect Dis 1997, 24:1131-1134.
63. Toltzis P, Yamashita T, Vilt L, Blumer JL: Colonization with antibiotic-resistant gram-negative organisms in a pediatric intensive care unit Crit Care Med 1997, 25:538-544.
64. Johanson WG, Pierce AK, Sanford JP: Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli. N Engl J Med 1969, 281:1137-1140.
65. Bingen E, Denamur E, Lambert-Zechovsky N, Brahimi N, El Lakany M, Elion J: Rapid genotyping shows absence of cross-contamination in Enterobacter cloacae nosocomial infections. J Hosp Infect 1992, 21:95-101.
66. Chetchotisakd P, Phelps CL, Harstein AI: Assessment of bacterial cross-contamination as a cause of infections in patients in intensive care units. Clin Infect Dis 1994, 18:29-37.
67. Talon D, Capellier G, Boillot A, Michel-Birand Y: Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit. Intensive Care Med 1995, 21:996-1002.